Strengthening research partnerships for better health and sustainable development
HIV inhibitory antibodies elicited by heterogeneous HIV-DNA prime boosted with HIV-MVA vaccine in healthy Tanzanian volunteers
PedVACC 001 and 002: building foundations for infant HIV-1 vaccine trials against breast milk transmission of HIV-1
Therapeutic HIV-1 vaccination of untreated healthy HIV-1 positive individuals in the Republic of Guinea Bissau using HLA-supertype CTL epitope peptides in new CAF01 adjuvant: a phase 1 study
AFREVACC 001: feasibility and acceptability of an HIV vaccine trial among men in Johannesburg, South Africa
Measuring adherence to antiretroviral therapy in northern Tanzania: feasibility and acceptability of the medication event monitoring system
Evaluation of HIV-1 viral load among mothers in a PTMCT programme with CD4 count above 350 cells/μl
Intrapartum single-dose carbamazepine shortens nevirapine elimination half-life and may reduce resistance
Nevirapine-associated hepatotoxicity and rash among HIV-infected pregnant women in Kenya
Efficacy and safety of immediate versus deferred initiation of HAART in TB/HIV co-infected patients with CD4 counts <200 cells/μl
High plasma efavirenz, slow NAT2 acetylators and ABCB1 genotype are associated with antitubercular and efavirenz-based ARV drugs induced liver injury in TB-HIV patients
Case definition for immune reconstitution inflammatory syndrome in HIV-schistosomiasis co-infected patients undergoing HAART
Immune reconstitution inflammatory syndrome among HIV/AIDS patients during highly active antiretroviral therapy in Addis Ababa, Ethiopia
Behavioural determinants for HIV incident infections in a fishing population being prepared for future HIV prevention research
Transmission clusters and evidence of HIV-1 transmitted drug resistance among recently infected ART-naive individuals from Ugandan fishing communities of Lake Victoria
Is the fishing community a hotbed for HIV and STI transmission? Evidence from Mangochi, Malawi
An assessment of the quality of life of HIV/AIDS patients and their families during the scaling-up of antiretroviral treatment in Ghana
Bacterial vaginosis as a risk factor for acquiring sexually transmitted diseases
Prevalence of anogenital human papilloma virus among PLWHA in Ibadan, Nigeria
Prevalence of human papilloma virus infection in HIVinfected women during the third trimester of pregnancy
Attitudes and intentions of mothers and adolescent daughters regarding human papilloma virus vaccination in Akinyele local area, Rachuonyo
HIV-positive women in Enugu, Nigeria: an assessment of current use of cervical cancer screening and willingness to pay in the absence of donor support
Prevalence and risk factors of major depressive disorders in HIV/AIDS as seen in semi-urban Entebbe District, Uganda
Cohort study among female bar and hotel workers in Tanzania in preparation for phase III microbicide and other HIV intervention clinical trials
Prevalence of reproductive tract infections (RTI) in women targeted for microbicide trials: the microbicide safety biomarkers study in Kenya, Rwanda, and South Africa
Community trial to prevent HIV/STDs among rural youths in post-confiict Liberia
Methicillin resistant Staphylococcus aureus nasal carriage in HIV-infected patients in Lagos, Nigeria
HIV-1 subtype distribution, multiple infections, sexual networks and partnership histories in female sex workers in Kampala, Uganda
Influence of HLA class I and HLA-KIR compound genotypes on HIV-2 infection and markers of disease progression in a community in West Africa
Evolution of neutralizing antibodies against HIV-1C molecular envelope clones from acute heterosexually acquired infections in Botswana
Assessment of TB-HIV treatment responses in co-infected patients receiving combined treatment
High prevalence of Hepatitis B and syphilis co-infection among newly diagnosed HIV patients in the northwest region of Cameroon
The ANRS initiative on clinical trials good clinical practices in resource-limited countries: development of quality indicators
The missing link in capacity building and training of basic science researchers in HIV/AIDS: lessons learnt in Botswana
Implementation, technology transfer and quality assessment in four African sites of a real-time PCR test to diagnose HIV-1 in exposed infants: the Promise PEP ANRS 12174 trial
Using an open source electronic data-capturing system for clinical trials in low-income countries
Bacterial vaginosis in women of reproductive age in Osun State, south western Nigeria
Prevalence of sexually transmitted infections among women attending antenatal clinics in northeastern Tanzania
The LEDGINs: first-in-class allosteric HIV-1 integrase inhibitors
Toxicity grading in clinical trials: implications for the use of western derived laboratory toxicity grading values
Lipid profiles in two groups of HIV-1 infected patients in Cameroon on two treatment regimens with either efavirenz or nevirapine, in association with RTI
Training and strategy for HIV drug resistance testing in eastern Africa
Liver enzyme abnormalities and associated risk factors in HIV patients on efavirenz-based HAART with or without tuberculosis co-infection in Tanzania
Nigerian surveillance program: assessing the status of HIV and reproductive health indicators
Measuring outcomes in OVC/HIV programming using the Civil Society Fund (CSF) model
Trends in HIV related risky sexual behaviour among fishing communities participating in a cohort for future HIV prevention trials
Pregnancy rates and associated factors in an HIV high risk community-based fishing population cohort along Lake Victoria Shores, Uganda
Evaluation of HIV incidence during pregnancy in Ouagadougou, Burkina Faso
Investigating monocyte and alveolar macrophage dysfunction in HIV-TB co-infection
Pattern of HIV-specific IFN-γ responses, CD4 counts, viral load trajectory and CD8 mediated virus inhibition in recently HIV-1-infected Ugandans
Fishing expedition in Botswana: search for plasma with broadly neutralizing antibodies against HIV-1
Molecular characterization and phylogeographic analysis of HIV-1 strains of chronically and recently infected individuals in Kigali, Rwanda
Novel modular teaching of HIV patients and effect on adherence to HAART
HIV-positive status disclosure to sexual partner among women attending Hawassa University Referral Hospital, south Ethiopia
The role of community caregivers in the care of HIV/AIDS patients in Lambwe Division, rural Kenya
Fishing, HIV and sex: exploring transactional sex and gender based violence in fishing communities in southern Malawi
Mitigating the impact of HIV/AIDS among pupils in Bolifamba and Muea Communities of the southwestern region of Cameroon
Perceptions of HIV/AIDS infection in a gerontological sexology study in Nigeria
Disclosure of HIV/AIDS status to sexual partners as a preventive measure
Correlates of study dropout in a fisher folk HIV vaccine preparedness observational cohort, Uganda
Adolescents’ perception of HIV vaccine trials in Nigeria
Preparation of a young adults’ cohort for HIV vaccine trials: experience from Dar es Salaam, Tanzania
Bivalent paediatric vaccine against HIV-1 and M. tuberculosis: pre-clinical development of BCG.HIVA222 strain
HIV pre-vaccine cohort with female commercial sex workers (CSW) in Ouagadougou, Burkina Faso: is the youngest group suitable as most-at-risk population?
PanACEA: using brokering to develop a research agenda
An international multicentre controlled clinical trial to evaluate high dose rifapentine and a quinolone in the treatment of pulmonary tuberculosis (rifaquin)
Plasma levels of tuberculosis drugs in TB patients in northern Tanzania
Optimization of TB and HIV co-treatment: pharmacokinetic and pharmacogenetic aspects of interaction between rifampicin and efavirenz (EFV)
Comparison of yield in sputum smear microscopy from specimens collected at different times in the diagnosis of pulmonary tuberculosis
Optimal number of samples required to diagnose tuberculosis by sputum culture among HIV-infected smear-negative TB suspects in Kampala, Uganda
Comparison of performance between Ziehl Neelsen (ZN) microscopy and the Xpert MTB/RIF assay in detection of M. tuberculosis in sputum at KEMRI/CDC TB lab
Cycle-threshold (CT) values of an automated TB-specific PCR platform (Xpert Mtb/RIF) as a predictor of smear status and grade
High mortality risk among individuals assumed to be TB-negative can be predicted using a simple test
Population structure of M. africanum and differences in ESAT-6 immunogenicity between different lineages
Development of a rapid serological screening test for tuberculosis
Distinct phases of changes in host gene expression reflect successful tuberculosis drug treatment
M. tuberculosis-specific lung innate immunity in close contacts of TB index cases
Variation in IFN-γ responses to different infecting strains of M. tuberculosis in acid-fast Bacillus smear-positive patients and household contacts
Decreased IFN-γ and increased Cd4+ Cd25+ Foxp3+ regulatory T-cells in patients with extensively drug resistant tuberculosis (XDR-TB)
Cellular and soluble biomarkers in the pleural fluid, absent from the peripheral blood, accurately diagnose pleural TB in a TB-endemic setting
Clinical trials with MVA85A, a candidate TB vaccine
A phase I study evaluating the safety and immunogenicity of a new TB vaccine, MVA85A, in healthy volunteers who are infected with HIV in Senegal
VPM1002 in a phase II clinical trial: all steps to neonate immunization
Updates from a randomised, double blind placebo controlled phase IIb tuberculosis vaccine trial in HIV-negative infants in Western Kenya
Reduced frequency of specific IFN-γ producing T-cells in Ugandan infants when Bacillus Calmette-Guerin vaccination is delayed from birth to 6 weeks of age
In silico mapping of M. tuberculosis proteins for CD4+ T-cell epitopes
Detailed functional assessment of the immune response to M. tuberculosis in HIV/TB co-infected individuals
M. tuberculosis complex within the tuberculosis case contact study in MRC Unit The Gambia
Estimates of genetic variability of M. tuberculosis complex and its association with drug resistance in Cameroon
Nanomedicine for improved efficacy of tuberculosis drugs
Predominance of the Ghanaian strain of M. tuberculosis in the coastal region of Cameroon
Non tuberculous mycobacteria among children with suspected TB in a rural setting in Uganda
Risk factors for tuberculosis infection among adolescents in rural Uganda
Community sensitisation in preparation of enrolment of infants and adolescents into a study to assess TB incidence
Retention patterns of an adolescent cohort in western Kenya in preparation for future TB vaccine trials
Comparison between active and passive case finding of tuberculosis among adolescents in eastern Uganda
WANETAM TB capacity building in preparation of clinical trials in West Africa: case detection capacities training in MRC The Gambia Unit
PanACEA collaboration and communications platform
Tuberculosis, malaria and HIV/AIDS at the Hospital Sanatório de Luanda, Angola
Comparison of Ziel-Neelsen stain, ELISA and PCR techniques in diagnosis of pulmonary tuberculosis in Khartoum State
Reliability of mycolic acid IgG antibodies in the diagnosis of pulmonary tuberculosis among Sudanese patients
Detection of multidrug-resistant tuberculosis in Sudan using PCR method in comparison to the conventional proportional method
Use of rpoB gene in the diagnosis of multidrug-resistant tuberculosis in Sudan
Evaluation of new biomarkers for diagnosis of pulmonary TB
The kinetics of acid fast bacilli in smear-positive sputum samples
Nanomedicine for smart drug delivery in diseases of poverty: a case study of tuberculosis
Local content rifampicin-loaded starch nanoparticles for the rapid treatment of tuberculosis
Prevalence of MDR-TB among HIV patients attending the DOTS clinic in a national tuberculosis reference laboratory in Nigeria
Impact of chronic worm infection on host immunity to tuberculosis
Feasibility and acceptability of antimycolic acid antibodies in the diagnosis of pulmonary tuberculosis in TB/HIV co-infected patients
Mycobacterial infections in an urban hospital in The Gambia
HIV sero-prevalence among newly diagnosed adult pulmonary tuberculosis patients at Chest Clinic, Infectious Diseases Hospital, Kano, Nigeria
Diversity of M. tuberculosis genotypes circulating in Ndola, Zambia
Prevalence of tuberculosis (TB) infection and disease among adolescents in western Kenya, in preparation for future TB vaccine trials
Tuberculosis: new cases still substantial
The use of spoligotyping to determine the molecular epidemiology of M. tuberculosis complex circulating in The Gambia
Field experience of sputum collection for TB diagnostic workup in cohort of adolescents in a rural resource limited setting of Uganda
Practical considerations in recruitment and retention of adolescents for a rural community-based study in Eastern Uganda
Molecular tools for tuberculosis surveillance in southwest Nigeria: a capacity building and networking experience
Incentives to improve tuberculosis treatment adherence
Pattern of resistance to first line antituberculosis drugs in Ibadan, Nigeria: preliminary observations
Quality assessment of tuberculosis laboratory diagnosis in selected health facilities of public and private laboratories in Oromia Regional State, Ethiopia
Key considerations for dealing with high contamination rates in liquid culture (Mycobacterium growth indicator tube) in a TB laboratory
Ward admission and consenting challenges for sputum induction and gastric aspiration procedures in the infant TB cohort in Iganga, Uganda
An electronic surveillance system for intensified TB case detection in an adolescent cohort study, in preparation for future tuberculosis vaccine trials, western Kenya
Capacity building for tuberculosis vaccine clinical trials in South Africa and Senegal
A head-to-head comparison of four artemisinin-based combinations for treating uncomplicated malaria in African children: a randomised trial
Clinical research capacity development: the experience of the West African Network for Clinical studies of Antimalarial drugs (WANECAM)
Co-administration of artemisinin-based combination therapies (ACTs) and antiretroviral (ARV) drugs: any evidence of adverse events or poor ACT pharmacokinetic profile?
Efavirenz significantly affects pharmacokinetic exposure of artemether-lumefantrine in HIV-infected Ugandan adults
Assessment of the fixed-dose combination of artesunate mefloquine (ASMQ) as an alternative antimalarial treatment for children in Africa
Safety and efficacy of dihydroartemisinin-piperaquine versus artemether-lumefantrine in the treatment of uncomplicated P. falciparum malaria in Zambian children
Burden of malaria in HIV-positive pregnant women in Ibadan, Southwest Nigeria
Different approaches for delivery of intermittent preventive treatment with sulfadoxine pyrimethamine (IPTp/Sp) to pregnant women in Burkina Faso
Intermittent preventive therapy post-discharge (IPTpd) to prevent rebound severe malaria anaemia in young children
A simplified artesunate regimen for severe malaria in children
Fluid Expansion as Supportive Therapy (FEAST) trial: mortality after fluid bolus in African children
Rare clinical features on malaria in children in eastern Uganda
Safety and immunogenicity of prime-boost immunization of Kenyan adults with candidate malaria vaccines based on a chimpanzee Adenovirus and MVA
Safety and immunogenicity of heterologous prime-boost vaccine strategy with Adch63 ME-TRAP and MVA ME-TRAP in healthy adults and children in The Gambia
Antibody levels to Msp1-Block 2 Hybrid, GLURP R2 and As202.11 and the risk of malaria in under 5 year old children of Burkina Faso and Ghana: an Afro-Immuno Assay project
Studies of new adjuvants and formulations of GMZ2 with the aim to enhance immunogenicity
Challenges in carrying out multicentre clinical trials in a consortium: the GMZ2 experience
Successful experiences in setting up a new site for phase II malaria vaccine testing in Uganda
Prospective study of the incidence of clinical malaria in the malaria vaccine candidate GMZ2 future trial site
Baseline epidemiological study in preparation for a phase IIb efficacy trial of GMZ2 candidate malaria vaccine
A randomised controlled phase Ib trial of the malaria vaccine candidate GMZ2 in African children
Novel methods to diagnose malaria by detecting hemozoin in intra-erythrocytic parasites possible limitations
Validation of new biomarkers for monitoring P. falciparum reduced susceptibility/tolerance or resistance to artemisinin derivatives and partner drugs in Nigeria
Documented fever and malaria in pregnancy in Africa
High prevalence of P. falciparum dhfr mutations correlates with sulfadoxine pyrimethamine usage among pregnant women in Nigeria
Benchmarking two multisite intermittent preventive treatment of malaria in pregnancy (IPTp) clinical trials in five sub-Saharan countries
Impact of artemisinin-based combination therapy on malaria transmission in Mali
Systematic screening and targeted treatment of P. falciparum asymptomatic carriers with artemether-lumefantrine in a community setting in Burkina Faso
The influence of mefloquine malaria prophylaxis on HIV disease progression: a randomised placebo-controlled trial
An opportunity to establish quality indicators and benchmarks for clinical laboratories supporting clinical trials in sub-Saharan Africa
Characteristics of some quality essentials in clinical laboratories in Nigeria
Using digital technology to support and enhance clinical trials in resource-limited settings
Evaluation of alternative antimalarial drugs to sulfadoxine-pyrimethamine for IPTP in the context of insecticide-treated nets
Ten years of experience with Coartem: A patient-centred approach to fighting malaria
Safety of artemisinins during early pregnancy, assessed in 62 Sudanese women
Pilot study on artesunate efficacy in non-severe malaria treatment in Mali
In vitro antiplasmodial activity and cytotoxicity evaluation of extracts of Acanthospermum hispidum DC and Ficus thonningii Blume
A randomised clinical trial of artemisinin versus nonartemisininbased combination therapy of uncomplicated malaria in Mali
A high compliance referral rate is achievable in under five children with severe malaria given emergency treatment at community level: the Ugandan experience
Clindamycin plus quinine: a forgotten antimalarial drug combination
Efficacy of sulfadoxine-pyrimethamine + amodiaquine versus sulfadoxine-pyrimethamine + artesunate versus sulfadoxine-pyrimethamine alone on uncomplicated falciparum malaria in Mali
Identification of natural antimalarial responses during repeated administration of three drug combinations based on artemisinin
Rapid clearance of peripheral P. falciparum schizonts by artesunate-amodiaquine and artemether-lumefantrine in Nigerian children with acute uncomplicated malaria
Efficacy of artesunate plus sulfadoxine-pyrimethamine and sulfadoxine-pyrimethamine alone in the treatment of uncomplicated P. falciparum malaria in Sinnar, central Sudan
Fighting malaria by making accessible anti-malaria mosquito repellent to Burundians
Predation efficiency of Anopheles gambiae larvae by aquatic predators in western Kenya highlands
New exposure methods for measuring mosquito behaviour which influences malaria transmission intensity and the impact of vector control
Community empowerment on the use of treated bed nets: Does it have an effect on the burden of malaria in children under five?
Cytokine and antibody levels and prevalence of congenital and neonatal malaria in Mali
Impact of maternal P. falciparum infection on immunological and haematological parameters on pregnancy and birth outcomes in Douala, Cameroon
Malarial iron-deficiency anaemia among asymptomatic Nigerian children
Malaria in children under 10 years of age living in a suburban area of Makelekele (Brazzaville, Congo): preliminary data
Spatial distribution and risk factors of malaria in infancy in Entebbe, Uganda
Foetal and maternal haemodynamics during acute malaria: persistent maternal tachycardia after recovery from malaria
Assessing malaria morbidity during the first 2 years of life in two different malaria epidemiological settings in Senegal and Burkina Faso
Slow parasite clearance and recrudescence in malaria patients treated with artemether-lumefantrine (AL): association with the NFD haplotype of PfMDRI
The evaluation of easy access groups as a tool for monitoring temporal changes in malaria transmissions and uptake of control interventions in Malawi: the EvalMal study
Baseline malaria epidemiology and normal reference ranges for biological parameters in Maferinyah, Guinea
The ABO blood group system and P. falciparum infection in three ethnic groups living in a stable and seasonal malaria transmission area of Burkina
Malaria morbidity during the two first years of life in rural Senegal
Defining malaria burden from morbidity and mortality records, self treatment practices and serological data in Magugu, Babati District, northern Tanzania
Comparison between molecular and conventional diagnostic tools for the diagnosis of malaria and sickle cell gene carriage
Marker value of microparticles in severe malaria associated with cerebral dysfunctions
Molecular diagnosis of malaria in the field: development of a novel 1-step nucleic acid lateral flow immunoassay for the detection of all four human Plasmodium species and its evaluation in Mbita, Kenya
Evaluation of the relative performance of rapid diagnostic test products (Partec and Paracheck-Pf) in the diagnosis of malaria in febrile children
Deficiency of CD36 predisposes children to clinical malaria
Determination of G6pd polymorphisms and their effects on antibody responses to malarial antigens in Rift Valley area of northern Tanzania
Geographic patterns of PfCRT and PfMDR1 polymorphisms in P. falciparum isolates from Nigeria and Brazil: evidence of different antimalarial drugs selection pressure
Pharmacogenetics determines treatment outcome of Lapdap in malaria
Genetic polymorphism of merozoite surface protein-1 and 2 in P. falciparum isolates from Brazzaville, Congo
Correlation between P. falciparum in vitro chloroquine resistance and level of PfCRT 76 T gene expression in Mali
Genome wide adaptations of P. falciparum in response to lumefantrine selective drug pressure
GIA, ELISA and protection in a P. knowlesi model
Implementation and standardization of in vitro P. falciparum culture in Africa
PfMDR1 codon 86 polymorphism: easy and effective solutions to practical challenges with DNA extraction, PRC amplification and gel documentation
Hyperparasitaemia and delayed parasite clearance after ACTs treatment in Nigerian children with acute uncomplicated falciparum malaria
Assessment of laboratory reference values in the Kassena-Nankana districts of northern Ghana
Clinical laboratory reference ranges derived from population living in a malaria endemic area of Burkina Faso
Networking to improve laboratory performance in a multicentre clinical trial in African centres
The East African Consortium for Clinical Research - malaria node external quality assurance programme for microscopy techniques
Ethical challenges in the conduct of the study-evaluation of four artemisinin-based combinations for the treatment of uncomplicated malaria in African children at the Ndola site
Perception, knowledge and practices regarding malaria of the Congolese population and its willingness to participate in clinical trials
Characterization of the Iganga (Uganda) trial site for phase IIb study of GMZ2 malaria vaccine candidate
Hematologic and blood chemistry reference ranges for Ugandan children in the Iganga-Mayuge demographic surveillance site for vaccine trial preparation
Association of antibody levels to multiple malaria vaccine candidate antigens with protection against clinical malaria episodes in children 1-5 years old in Mali
Holistic capacity building through the EDCTP funded GMZ2 consortium
Baseline epidemiological study in preparation for a phase IIb proof of concept efficacy study of the GMZ2 candidate malaria vaccine: results from Lambaréné, Gabon
PACTR: An update on prospective clinical trial registration in Africa
Emerging ethical and practical challenges for health researchers in Africa
Mapping African research ethics review and medicines regulatory capacity
TRREE online training project: mapping its first 2 years
Understanding participants' consent in an entero-toxigenic vaccines trial in the Misisi Township in Lusaka, Zambia
Training of lay members of ethics committees on how to review protocols
Improving efficiency of ethics review in Zimbabwe through decentralization
Building effective and sustainable partnerships for global health research: the useful role of a partnership assessment tool
Data management in non-commercial north-south collaborative clinical research: lessons learned from some EDCTP trials
ISHReCA: Consolidating gains and setting new directions for longer term impact and sustainability in health research capacity building in Africa
Building clinical research capacity through an adaptable modular approach: the applied research and evidence based medicine course
Barriers to evidence-based practice in doctors and nurses in Rwanda and Uganda
Knowledge, attitudes and practice of evidence-based medicine in doctors and nurses in Rwanda and Uganda
Opportunities and challenges in establishing an environment conducive to research in academic institutions in resource-limited countries
Development and field evaluation of a set of more affordable HIV treatment monitoring technologies for Africa: the ART-A project
Building a sustainable Eastern Africa network for capacity strengthening and mentoring in research and health
The West African Node of Excellence for TB, AIDS and Malaria (WANETAM)
CANTAM for conduct of clinical trials
TESA: A model of clinical research capacity building in Southern Africa
Operationalising a multi-centre trial in critically ill African children in resource limited settings
Capacity building for research synthesis and conduct of Cochrane systematic reviews in Africa
Using OpenClinica in data management in malaria studies at the clinical trials facility in Kilifi
Gaining recognition as an ‘African centre of excellence in applied nanomedicine research and training for poverty related diseases’
EDCTP capacity building achievements at the International Centre For Reproductive Health (ICRH) clinical research laboratory in Mombasa, Kenya
Capacity development by creating a laboratory science training module for Africa
CANTAM-AMANET-CAMBIN: a winning trio for promoting health research ethics in central Africa
Keur Soce health and demographic surveillance site system in Senegal: site description, baseline findings and policy implication
Developing capacity for carrying out clinical trials in the private sector at the grass root level in Ghana
Assessing participants' understanding and voluntariness of informed consent in a clinical trial in Nigeria
Strengthening of an African Institutional Review Committee through North-South collaborations: the TASO Uganda experience
Structural and functional status of research ethics committees in Cameroon
Active monitoring of approved research protocols in Cameroon
Role of National Institutional Review Boards (IRBs) in protection of research participants: experiences from the Medical Research Council of Zimbabwe
Striving for a comprehensible informed consent
Establishing and strengthening health research ethics committees in Ethiopia
A multi-step approach to informed consent: the experience from 2LADY, a second line ART randomised clinical trial
Strengthening research ethics review capacity: the Botswana case
Egyptian Network of Research Ethics Committees (ENREC)
A new paradigm in health research ethics in Liberia
Strengthening ethical and regulatory review capacity in Africa: unfinished business
Navigating the terrain of human subjects protection in Malawi
Successful management of an EDCTP collaborative grant by the Uganda Virus Research Institute-IAVI HIV Vaccine Programme
Impact of strengthening research grants management capacity
Experiences from an internal quality assurance programme
Reciprocal monitoring: a pragmatic regional approach to quality assurance in health research
Using internal monitoring to build capacity and support networks of excellence
System and tools for evaluation and survey of health research in Senegal
Clinical trials monitoring in Nigeria: the experience of Zeta-12, a clinical research organisation
Current paradigms in regulatory quality assurance: a panacea for the challenges in the Nigerian regulated research industry
The regulatory pathway for a vaccine intended for developing countries: a case study of RTS,S As01
Promoting rational drug use among rural women in Egbeda local government of Oyo State, Nigeria